Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 16 (RPL21P16)

Target: RPL21P16
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L21 pseudogene 16 (RPL21P16) is a processed pseudogene found in the human genome. Pseudogenes are DNA sequences that originate from previously functional genes but have lost their ability to encode proteins due to mutations or deletions. RPL21P16 is one of several pseudogenes related to the ribosomal protein L21 gene (RPL21). It does not produce a functional ribosomal protein and is not therapeutically relevant. While the functional RPL21 gene encodes a structural component of the 60S ribosomal subunit involved in protein synthesis, RPL21P16 itself does not play an active role in cellular physiology or disease[3][6][7].

Other names: Em:AC073587.1RPL21_38_1104RPL21P16

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 16 (RPL21P16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 16 (RPL21P16).

Explore the full profile